Education
About Us
Working with TipRanks
Follow Us
Soligenix Inc (SNGX)
:SNGX
Hypericin
Cutaneous T Cell Lymphoma, Mycosis Fungoides, Ctcl/ Mycosis Fungoides, Ctcl
Phase III
Recruiting
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
Jun 17, 2024
―
Dusquetide
Behçet Disease
Phase II
Completed
Dusquetide for the Treatment of Behcet's Disease
Apr 23, 2024
―
Hypericin, Mechlorethamine Topical Gel
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Phase II
Completed
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Nov 20, 2023
―
Hypericin
Psoriasis, Plaque Psoriasis, Psoriasis Vulgaris
Phase II
Recruiting
Topical SGX302 for Mild-to-Moderate Psoriasis
Jun 28, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Soligenix Inc (SNGX) have in its pipeline
SNGX is currently developing the following drugs: Hypericin, Dusquetide, Hypericin, Mechlorethamine Topical Gel. These drug candidates are in various stages of clinical development as the company works toward FDA approval.